Allan Oberman
Allan Oberman is the Chief Executive Officer of Apotex Inc., Canada’s largest pharmaceutical company, which is planning a $1-billion initial public offering. With a background as a former executive at Teva Pharmaceutical Industries, Oberman brings extensive experience in the generic drug sector. He has been instrumental in leading Apotex's strategic direction towards producing affordable medicines and expanding its product portfolio.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 5.00 | 0.92% | +0% | 38,005,238 | 348,672 | $1,700,000 | 15,596$ |
| Totals | 1 | 38,005,238 | 348,672 | $1,700,000 | 15,596$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Allan Oberman was the chief executive officer of Apotex before being replaced in March.
5
Canada:
Allan Oberman is the CEO of Apotex and is leading a marketing campaign for the company.
7